Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China · Delayed Price · Currency is CNY 18.11
+0.41 (2.32%)
Apr 8, 2026, 3:04 PM CST
SHE:000739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 890.68 | 1,031 | 1,055 | 989.17 | 955.55 |
Depreciation & Amortization | 668.8 | 578.02 | 553.06 | 389.43 | 358.64 |
Other Amortization | 9.3 | 6.25 | 5.93 | 5.18 | 3.92 |
Loss (Gain) From Sale of Assets | -9.03 | -0.28 | -1.33 | -1.37 | -0.28 |
Asset Writedown & Restructuring Costs | 5 | 8.37 | 7.79 | 4.67 | 55.84 |
Loss (Gain) From Sale of Investments | -30.19 | -6.21 | 18.08 | 82.61 | -66.73 |
Provision & Write-off of Bad Debts | -9.64 | 9.49 | 1.92 | 12.71 | - |
Other Operating Activities | 124.12 | 54.19 | 164.86 | 12.27 | -13.57 |
Change in Accounts Receivable | -227.87 | -251.45 | -571.63 | -1,108 | -851.44 |
Change in Inventory | 165.58 | 152.99 | -373.35 | -603.07 | -190.08 |
Change in Accounts Payable | -342.74 | -375.3 | 130.17 | 1,649 | 373.38 |
Change in Other Net Operating Assets | 0.53 | 0.56 | 36.87 | -2.74 | 0.5 |
Operating Cash Flow | 1,220 | 1,209 | 1,031 | 1,326 | 611.75 |
Operating Cash Flow Growth | 0.95% | 17.20% | -22.23% | 116.77% | -42.26% |
Capital Expenditures | -386.21 | -460.75 | -630.47 | -509.11 | -701.92 |
Sale of Property, Plant & Equipment | 33.03 | 8.51 | 8.96 | 4.87 | 3.88 |
Divestitures | 30.18 | 7.6 | 30.4 | - | - |
Investment in Securities | -59.62 | 34.76 | -77.9 | -5.78 | 92.56 |
Other Investing Activities | 10.31 | 11.86 | -7.79 | -81.29 | 90.1 |
Investing Cash Flow | -372.32 | -398.01 | -676.8 | -591.3 | -515.39 |
Long-Term Debt Issued | 2,135 | 1,388 | 1,061 | 1,085 | 805.16 |
Total Debt Issued | 2,135 | 1,388 | 1,061 | 1,085 | 805.16 |
Long-Term Debt Repaid | -1,424 | -1,416 | -980.02 | -725.88 | -707.57 |
Total Debt Repaid | -1,424 | -1,416 | -980.02 | -725.88 | -707.57 |
Net Debt Issued (Repaid) | 711.08 | -27.93 | 81.16 | 359.57 | 97.59 |
Repurchase of Common Stock | -482.06 | -153.09 | - | -200.2 | - |
Common Dividends Paid | -836.11 | -401.63 | -383.02 | -362.8 | -301.92 |
Other Financing Activities | -36 | 0.51 | 0.38 | 7.35 | - |
Financing Cash Flow | -643.09 | -582.15 | -301.48 | -196.09 | -204.32 |
Foreign Exchange Rate Adjustments | -9.95 | 38.37 | 27.49 | 44.04 | -17.32 |
Net Cash Flow | 194.85 | 266.96 | 80.57 | 582.76 | -125.29 |
Free Cash Flow | 833.99 | 748.01 | 400.9 | 817 | -90.18 |
Free Cash Flow Growth | 11.49% | 86.58% | -50.93% | - | - |
Free Cash Flow Margin | 8.52% | 6.22% | 3.49% | 7.75% | -1.01% |
Free Cash Flow Per Share | 0.72 | 0.64 | 0.34 | 0.70 | -0.08 |
Cash Income Tax Paid | 112.51 | 27.07 | -2.88 | -41.97 | 149.94 |
Levered Free Cash Flow | 672.82 | 504.46 | -28.58 | 1,366 | 554.62 |
Unlevered Free Cash Flow | 688.23 | 524.58 | -1.23 | 1,403 | 576.94 |
Change in Working Capital | -428.82 | -472.2 | -774.29 | -168.56 | -681.62 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.